Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07039591 · ClinicalTrials.gov registry record · Early Phase 1
Assess Performance Attributes and Acceptability of Non-medicated Intravaginal Rings Among Sexually Active Women in Atlanta, GA
A Early Phase 1 study of Contraceptive Usage, sponsored by Population Council.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT07039591: Recruiting Early Phase 1 study of Contraceptive Usage, sponsored by Population Council.
NCT07039591 is a Early Phase 1 study of Contraceptive Usage that is actively recruiting participants, run by Population Council. The registered enrollment target is 60 participants, below the 623-participant average among 11 other Contraceptive Usage trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07039591, a Early Phase 1 study of Contraceptive Usage, is actively recruiting participants, sponsored by Population Council.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
A randomized open label crossover trial to assess performance attributes and acceptability of non-medicated intravaginal rings among sexually active women in Atlanta, GA
Primary Outcome
For the primary outcome we will compute the mean acceptability score per IVR, for each of three IVRs of different compression strengths. The scores women give each of the three rings will be compared using a mixed-effects model with orthogonal contrasts, with all 3 pairwise comparisons using the Bonferroni method to adjust for multiple comparisons.
Conditions Studied
Interventions
- DEVICE Pro-type IVR
Study Locations (1)
Georgia
- Emory University - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-08-08 |
| Est. Completion | 2026-10-30 |
| Phase | Early Phase 1 |
What NCT07039591 shows while recruiting
NCT07039591 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 623-participant average among 11 other Contraceptive Usage trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Contraceptive Usage appearing as the primary indexed condition, and to 1 intervention - of which Pro-type IVR is the first listed.
NCT07039591 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT07039591 about?
NCT07039591 is a clinical study titled "Assess Performance Attributes and Acceptability of Non-medicated Intravaginal Rings Among Sexually Active Women in Atlanta, GA". A randomized open label crossover trial to assess performance attributes and acceptability of non-medicated intravaginal rings among sexually active women in Atlanta, GA
What is the current status of trial NCT07039591?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 60 participants. The study started on 2025-08-08. Estimated completion is 2026-10-30.
What conditions does trial NCT07039591 study?
This clinical trial studies the following conditions: Contraceptive Usage.
What interventions are being tested in trial NCT07039591?
The interventions under investigation include: Pro-type IVR (DEVICE).
Who is sponsoring clinical trial NCT07039591?
This trial is sponsored by Population Council, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07039591 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Contraceptive Usage
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07039591's enrollment target sits among peer trials
60 9th of 11 higher than 3 of 11 other Contraceptive Usage trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Contraceptive Usage trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Inpatient Adolescent Contraception
COMPLETED · Early Phase 1
-
Disparities in Emergency Contraceptive Metabolism Dictate Efficacy
RECRUITING · Phase 4
-
Effectiveness Testing of a Videogame Intervention (No Baby No) to Decrease Contraception Non-use Among Adolescents.
RECRUITING · NA
-
RCT Evaluating Standardized Counseling on Early Discontinuation for Irregular Bleeding in Nexplanon Users
ACTIVE NOT RECRUITING · Phase 4
-
The Over The Counter Pill National Study
ACTIVE NOT RECRUITING
-
Sexual Health Empowerment for Women's Health
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI